Document
Summary
Therapeutic immunoglobulin is recommended to be available as a routinely commissioned treatment option for the indications within the criteria set out in these documents.
Document
Summary
The Commissioning criteria policy for the use of therapeutic immunoglobulin (Ig) England, 2021, has been converted into a policy template with an update of the document following publication. These changes were agreed previously (v1.0 – unpublished) and do not form part of this change form.
Document
Summary
Outline of the criteria required by the the Clinical Priorities Advisory Group (CPAG) for the commissioning criteria policy for the use of therapeutic Immunoglobulin.
Document
Summary
A copy of the Equality and Health Inequalities Impact Assessment (EHIA) form.
Document
Summary
Changes made to the clinical commissioning policy on therapeutic Immunoglobulin as a result of stakeholder testing.